Licensing News
🌏 NMPANMPA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–5 of 5 articles
Earlier
High impact NewsJun 7, 2026
Fosun Pharma and AriBio Forge Alzheimer's Option Agreement: Deal Intelligence
FDA · Alzheimer's · 8 min
Dr. Yuki TanakaHigh impact NewsJun 3, 2026
Big Pharma's China Oncology Trials: Navigating a Landscape of Reduced Scrutiny
FDA · oncology · 5 min
Dr. Yuki TanakaHigh impact NewsJun 3, 2026
Kissei Pharmaceutical Halts Tavneos Use Amid Deaths
FDA · 6 min
Dr. Yuki TanakaCritical impact NewsJun 2, 2026
BeOne Medicines' HERIZON-GEA Phase 3 Data in NEJM: A Deep Dive for Pharma BD and Investors
FDA · 6 min
Dr. Yuki TanakaHigh impact NewsApr 21, 2026
Biogen Acquires Felzartamab Rights from TJ Biopharma for Greater China Market
2 min
Dr. Yuki TanakaExplore intelligence